Well guys, update was released. As mentioned in my last post, there may be a hint on the next press release. Sometimes we can’t see the Forest for the trees. (Focus on the big picture!) The update mentioned four international partners with signed agreements. Disclosure of these four international partners will be realized when certain events happen. We will be aware of these partners when deposits and purchase orders are in place. So how many press releases are expected? It’s not when the press releases come out but what is in the press releases. One more thing-How many more partners are going to come in for the worldwide rollout?
Don’t forget the new clinical trials that will commence soon. What’s this about??? Have you all given it any thought?
“Expect the Expected”
The company is strengthening the OEM, now what does this mean if not for huge orders coming in and future growth? They are planning for tomorrow not for today!
Real time marketing and advertising has not started yet! Wait until it starts, none of the great posters will be able to keep track on how many stores the products are in nor will they be able to keep track of sales in North America. I’m not even talking about the world wide rollout. Good luck to all trying to keep track.
Market makers do what they do also traders do what they do to keep the price down. How long can they do this? Revenue growing, profits coming their days are numbered.
Last but not least-New extensions on the OTC devices including clinical trials!
Share structure, note holders. What reactions were created by these actions? Clinical trials were created, FDA clearances, partners, revenue, etc. It’s not the share structure or the note holders better still the debt holders that are bringing the price down but in reality this is what is going to bring the price up. The company is alive and well thanks to what or who is stated above. As in most cases if not all, a company cannot grow if it does not have debt. It’s a proven fact! Just like you and me, we need a loan to buy a property or a business. This loan is a debt! Do not listen to any negative poster about share structure because in reality, that’s why we are still here today.
Yes there may be a share buyback but I do see a buyout coming first.
Stay focussed.
Don’t forget the new clinical trials that will commence soon. What’s this about??? Have you all given it any thought?
“Expect the Expected”
The company is strengthening the OEM, now what does this mean if not for huge orders coming in and future growth? They are planning for tomorrow not for today!
Real time marketing and advertising has not started yet! Wait until it starts, none of the great posters will be able to keep track on how many stores the products are in nor will they be able to keep track of sales in North America. I’m not even talking about the world wide rollout. Good luck to all trying to keep track.
Market makers do what they do also traders do what they do to keep the price down. How long can they do this? Revenue growing, profits coming their days are numbered.
Last but not least-New extensions on the OTC devices including clinical trials!
Share structure, note holders. What reactions were created by these actions? Clinical trials were created, FDA clearances, partners, revenue, etc. It’s not the share structure or the note holders better still the debt holders that are bringing the price down but in reality this is what is going to bring the price up. The company is alive and well thanks to what or who is stated above. As in most cases if not all, a company cannot grow if it does not have debt. It’s a proven fact! Just like you and me, we need a loan to buy a property or a business. This loan is a debt! Do not listen to any negative poster about share structure because in reality, that’s why we are still here today.
Yes there may be a share buyback but I do see a buyout coming first.
Stay focussed.
4
1
